Related Experiment Video
Updated: Dec 20, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
A Static Magnetic Field Inhibits the Migration and Telomerase Function of Mouse Breast Cancer Cells
Zhu Fan1, Pingdong Hu2,3, Lekang Xiang1
1School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Abstract:
Static magnetic field (SMF) has a potential as a cancer therapeutic modality due to its specific inhibitory effects on the proliferation of multiple cancer cells. However, the underlying mechanism remains unclear, and just a few studies have examined the effects of SMF on metastasis, an important concern in cancer treatment. In this study, we evaluated the effects of moderate SMF (~150 mT) on the proliferation and migration of 4T1 breast cancer cells. Our results showed that SMF treatment accelerated cell proliferation but inhibited cell migration. Further, SMF treatment shortened the telomere length, decreased telomerase activity, and inhibited the expression of the cancer-specific marker telomerase reverse transcriptase (TERT), which may be related to expression upregulation of e2f1, a transcription repressor of TERT and positive regulator of the mitotic cell cycle. Our results revealed that SMF repressed both, cell migration and telomerase function. The telomerase network is responsive to SMF and may be involved in SMF-mediated cancer-specific effects; moreover, it may function as a therapeutic target in magnetic therapy of cancers.
Insights
Static magnetic field (SMF) therapy may treat cancer by affecting cell proliferation and migration. SMF impacts telomere length and telomerase reverse transcriptase (TERT) expression, suggesting a potential therapeutic target.
Area of Science:
- Oncology
- Biophysics
Background:
- Static magnetic fields (SMF) show potential for cancer therapy by inhibiting cancer cell proliferation.
- Mechanisms of SMF action, especially on metastasis, require further investigation.
Purpose of the Study:
- To evaluate the effects of moderate SMF (~150 mT) on 4T1 breast cancer cell proliferation and migration.
- To elucidate the underlying molecular mechanisms of SMF's impact on cancer cells.
Main Methods:
- Exposure of 4T1 breast cancer cells to ~150 mT SMF.
- Assessment of cell proliferation and migration.
- Analysis of telomere length, telomerase activity, and telomerase reverse transcriptase (TERT) expression.
- Investigation of e2f1 expression levels.
Main Results:
- SMF treatment accelerated 4T1 cell proliferation but inhibited cell migration.
- SMF exposure shortened telomere length and decreased telomerase activity.
- SMF inhibited telomerase reverse transcriptase (TERT) expression, potentially linked to e2f1 upregulation.
- SMF repressed both cell migration and telomerase function.
Conclusions:
- SMF affects cancer cell proliferation and migration, with implications for metastasis.
- The telomerase network is responsive to SMF, indicating its role in SMF-mediated anti-cancer effects.
- Telomerase may serve as a therapeutic target in magnetic field cancer therapy.
More Related Videos
Related Concept Videos
Replicative Cell Senescence
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

